Anakinra/cladribine/cyclophosphamideLack of efficacy and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1885卷 / 1期

关键词：

D O I：

10.1007/s40278-021-06810-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：51 / 51

相关论文

共 50 条

[41] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1925 (1) : 348 - 348
[42] DexamethasoneLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1887 (1) : 259 - 259
[43] Multiple drugsLack of efficacy and off-label use : case report
Reactions Weekly, 2022, 1921 (1) : 191 - 191
[44] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1924 (1) : 308 - 308
[45] EculizumabLack of efficacy following off-label use: case report
Reactions Weekly, 2021, 1862 (1) : 196 - 196
[46] VenetoclaxLack of efficacy following off-label use: case report
Reactions Weekly, 2025, 2041 (1) : 398 - 398
[47] DexamethasoneLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1967 (1) : 143 - 143
[48] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1934 (1) : 304 - 304
[49] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1928 (1) : 256 - 256
[50] Alteplase/dexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1935 (1) : 29 - 29

← 1 2 3 4 5 →